1. THU0366 Efficacy of Adalimumab in Patients with Axial Spondyloarthritis: Results of an Investigator-Initiated 12-Weeks Randomized Double-Blind Placebo Controlled Trial with a 12 Weeks Open-Label Extension Phase. (23rd January 2014) Authors: Pedersen, S. J.; Sørensen, IJ; Loft, AG; Hindrup, JS; Thamsborg, G; Asmussen, K; Kluger, E; Nørregaard, J; Christensen, TG; Jurik, AG; Møller, JM; Hasselquist, M; Skjødt, T; Mikkelsen, D; Østergaard, M Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0062 Ex vivo back-translation of fostamatinib's effect on joint ecm turnover shows significant effect on bone but no effect on the synovium. (15th June 2017) Authors: Kjelgaard-Petersen, CF; Christensen, TG; Hägglund, P; Karsdal, MA; Thudium, CS; Bay-Jensen, A-C Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1068 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗